Cancer Center Amsterdam
-
Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis
Illini, O., Saalfeld, F. C., Christopoulos, P., Duruisseaux, M., Vikström, A., Peled, N., Demedts, I., Dudnik, E., Eisert, A., Hashemi, S. M. S., Janzic, U., Kian, W., Mohorcic, K., Mohammed, S., Silvoniemi, M., Rothschild, S. I., Schulz, C., Wesseler, C., Addeo, A., Armster, K., & 28 others, Apr 2024, In: International journal of molecular sciences. 25, 7, 3992.Research output: Contribution to journal › Article › Academic › peer-review
-
First exploration of the on-treatment changes in tumor and organ uptake of a radiolabeled anti PD-L1 antibody during chemoradiotherapy in patients with non-small cell lung cancer using whole body PET
Pouw, J. E. E., Hashemi, S. M. S., Huisman, M. C., Wijngaarden, J. E., Slebe, M., Oprea-Lager, D. E., Zwezerijnen, G. J. C., Vugts, D., Ulas, E. B., de Gruijl, T. D., Radonic, T., Senan, S., Menke-van der Houven van Oordt, C. W. & Bahce, I., 1 Feb 2024, In: Journal for Immunotherapy of Cancer. 12, 2, e007659.Research output: Contribution to journal › Article › Academic › peer-review
-
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
SAPPHIRE Investigators, Jan 2024, In: Annals of Oncology. 35, 1, p. 66-76 11 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications